[PubMed: 40081498] [Free Article] Gabery S, Glendorf T, Ballarin-Gonzalez B, et al
2017, pp
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
Sango and Utsunomiya, 2015)
Immune modulation: Peptides can reduce pathological inflammation without broadly suppressing immune function
Ships from the US and carries the full GLP-1 reference range alongside repair, longevity and cosmetic compounds